Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19
Article (Published version)
Metadata
Show full item recordAbstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is able to produce an excessive host immune reaction and may leads to severe disease- a life-threatening condition occurring more often in patients suffering from comorbidities such as hypertension, diabetes and obesity. Infection by human corona viruses highly depends on host microRNA (miR) involved in regulation of host innate immune response and inflammation-modulatory miR-146a is among the first miRs induced by immune reaction to a virus. Moreover, recent analysis showed that miR-146 is predicted to target at the SARS-CoV-2 genome. As the dominant regulator of Toll-like receptors (TLRs) downstream signaling, miR-146a may limit excessive inflammatory response to virus. Downregulation of circulating miR-146a was found in diabetes, obesity and hypertension and it is reflected by enhanced inflammation and fibrosis, systemic effects accompanying severe COVID-19. Thus it could be hypothesized that miR-146a deficie...ncy may contribute to severe COVID-19 state observed in diabetes, obesity and hypertension but further investigations are needed.
Keywords:
microRNA-146 / SARS-CoV-2 / Diabetes / Obesity / HypertensionSource:
Medical Hypotheses, 2021, 146, 110448-Publisher:
- Elsevier
DOI: 10.1016/j.mehy.2020.110448
ISSN: 0306-9877
PubMed: 33338955
WoS: 000614812300036
Scopus: 2-s2.0-85097768883
Collections
Institution/Community
Stomatološki fakultetTY - JOUR AU - Roganović, Jelena PY - 2021 UR - https://smile.stomf.bg.ac.rs/handle/123456789/2585 AB - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is able to produce an excessive host immune reaction and may leads to severe disease- a life-threatening condition occurring more often in patients suffering from comorbidities such as hypertension, diabetes and obesity. Infection by human corona viruses highly depends on host microRNA (miR) involved in regulation of host innate immune response and inflammation-modulatory miR-146a is among the first miRs induced by immune reaction to a virus. Moreover, recent analysis showed that miR-146 is predicted to target at the SARS-CoV-2 genome. As the dominant regulator of Toll-like receptors (TLRs) downstream signaling, miR-146a may limit excessive inflammatory response to virus. Downregulation of circulating miR-146a was found in diabetes, obesity and hypertension and it is reflected by enhanced inflammation and fibrosis, systemic effects accompanying severe COVID-19. Thus it could be hypothesized that miR-146a deficiency may contribute to severe COVID-19 state observed in diabetes, obesity and hypertension but further investigations are needed. PB - Elsevier T2 - Medical Hypotheses T1 - Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19 VL - 146 SP - 110448 DO - 10.1016/j.mehy.2020.110448 ER -
@article{ author = "Roganović, Jelena", year = "2021", abstract = "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is able to produce an excessive host immune reaction and may leads to severe disease- a life-threatening condition occurring more often in patients suffering from comorbidities such as hypertension, diabetes and obesity. Infection by human corona viruses highly depends on host microRNA (miR) involved in regulation of host innate immune response and inflammation-modulatory miR-146a is among the first miRs induced by immune reaction to a virus. Moreover, recent analysis showed that miR-146 is predicted to target at the SARS-CoV-2 genome. As the dominant regulator of Toll-like receptors (TLRs) downstream signaling, miR-146a may limit excessive inflammatory response to virus. Downregulation of circulating miR-146a was found in diabetes, obesity and hypertension and it is reflected by enhanced inflammation and fibrosis, systemic effects accompanying severe COVID-19. Thus it could be hypothesized that miR-146a deficiency may contribute to severe COVID-19 state observed in diabetes, obesity and hypertension but further investigations are needed.", publisher = "Elsevier", journal = "Medical Hypotheses", title = "Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19", volume = "146", pages = "110448", doi = "10.1016/j.mehy.2020.110448" }
Roganović, J.. (2021). Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19. in Medical Hypotheses Elsevier., 146, 110448. https://doi.org/10.1016/j.mehy.2020.110448
Roganović J. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19. in Medical Hypotheses. 2021;146:110448. doi:10.1016/j.mehy.2020.110448 .
Roganović, Jelena, "Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19" in Medical Hypotheses, 146 (2021):110448, https://doi.org/10.1016/j.mehy.2020.110448 . .